Relevant bibliographies by topics / French National Health Data System (SNDS)

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Book chapters
  4. Conference papers

Academic literature on the topic 'French National Health Data System (SNDS)'

Author: Grafiati
Published: 4 June 2021
Last updated: 25 January 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'French National Health Data System (SNDS).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "French National Health Data System (SNDS)"

1

Bounoure, Frederic, Damien Mouly, Pascal Beaudeau, et al. "Syndromic Surveillance of Acute Gastroenteritis Using the French Health Insurance Database: Discriminatory Algorithm and Drug Prescription Practices Evaluations." International Journal of Environmental Research and Public Health 17, no. 12 (2020): 4301. http://dx.doi.org/10.3390/ijerph17124301.

Full text
Abstract:
The French national public health agency (Santé publique France) has used data from the national health insurance reimbursement system (SNDS) to identify medicalised acute gastroenteritis (mAGE) for more than 10 years. This paper presents the method developed to evaluate this system: performance and characteristics of the discriminatory algorithm, portability in mainland and overseas French departments, and verification of the mAGE database updating process. Pharmacy surveys with certified mAGE from 2012 to 2015 were used to characterise mAGE and to estimate the sensitivity and predictive posi
APA, Harvard, Vancouver, ISO, and other styles
2

Touzeau, Cyrille, Matthieu Javelot, Marie Pierres, et al. "P-163: Mortality in patients with multiple myeloma: the mylord study from the french national health data system (SNDS)." Clinical Lymphoma Myeloma and Leukemia 22 (August 2022): S124—S125. http://dx.doi.org/10.1016/s2152-2650(22)00493-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dumas, Elise, Lucie Laot, Florence Coussy, et al. "The French Early Breast Cancer Cohort (FRESH): A Resource for Breast Cancer Research and Evaluations of Oncology Practices Based on the French National Healthcare System Database (SNDS)." Cancers 14, no. 11 (2022): 2671. http://dx.doi.org/10.3390/cancers14112671.

Full text
Abstract:
Background: Breast cancer (BC) is the most frequent cancer and the leading cause of cancer-related death in women. The French National Cancer Institute has created a national cancer cohort to promote cancer research and improve our understanding of cancer using the National Health Data System (SNDS) and amalgamating all cancer sites. So far, no detailed separate data are available for early BC. Objectives: To describe the creation of the French Early Breast Cancer Cohort (FRESH). Methods: All French women aged 18 years or over, with early-stage BC newly diagnosed between 1 January 2011 and 31
APA, Harvard, Vancouver, ISO, and other styles
4

Stenson, K., H. Hadjrabia, F. Boer, et al. "EE657 Health Resource Utilization by Disease Stage for People with Amyotrophic Lateral Sclerosis (pALS) in the French National Health Data System (SNDS)." Value in Health 26, no. 12 (2023): S180. http://dx.doi.org/10.1016/j.jval.2023.09.922.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jourdain, Hugo, Léa Hoisnard, Emilie Sbidian, and Mahmoud Zureik. "Persistence and safety of anti-TNF biosimilars versus originators in immune-mediated inflammatory diseases: an observational study on the French National Health Data System." RMD Open 10, no. 1 (2024): e003531. http://dx.doi.org/10.1136/rmdopen-2023-003531.

Full text
Abstract:
ObjectivesBiosimilar-originator equivalence has been demonstrated in phase 3 trials in a few indications of infliximab, etanercept and adalimumab. The objective of our study was to compare the persistence and safety of biosimilars versus originators in all the licensed indications of these molecules.MethodsWe used data from the French National Health Data System (SNDS), covering 99% of the French population, to identify infliximab, etanercept and adalimumab initiators from biosimilar launch (January 2015, May 2016 and October 2018, respectively) to 30 June 2021. Patients were then followed for
APA, Harvard, Vancouver, ISO, and other styles
6

Carcaillon-Bentata, Laure, Cécile Quintin, Marjorie Boussac-Zarebska, and Alexis Elbaz. "Prevalence and incidence of young onset dementia and associations with comorbidities: A study of data from the French national health data system." PLOS Medicine 18, no. 9 (2021): e1003801. http://dx.doi.org/10.1371/journal.pmed.1003801.

Full text
Abstract:
Background Dementia onset in those aged <65 years (young onset dementia, YOD) has dramatic individual and societal consequences. In the context of population aging, data on YOD are of major importance to anticipate needs for planning and allocation of health and social resources. Few studies have provided precise frequency estimates of YOD. The aim of this study is to provide YOD prevalence and incidence estimates in France and to study the contribution of comorbidities to YOD incidence. Methods and findings Using data from the French national health data system (Système National des Donnée
APA, Harvard, Vancouver, ISO, and other styles
7

Brousse, V., C. Badens, N. Quignot, et al. "PRO58 CLINICAL AND ECONOMIC BURDEN OF TRANSFUSION-DEPENDENT BETA-THALASSEMIA IN FRANCE: A RETROSPECTIVE ANALYSIS OF THE FRENCH NATIONAL HEALTH DATA SYSTEM (SNDS)." Value in Health 22 (November 2019): S851. http://dx.doi.org/10.1016/j.jval.2019.09.2388.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Bachelez, Hervé, Jacques Massol, Gérard de Pouvourville, et al. "26591 Characterization of flares in patients with generalized pustular psoriasis—A population-based study from the French National Health Data System database (SNDS)." Journal of the American Academy of Dermatology 85, no. 3 (2021): AB20. http://dx.doi.org/10.1016/j.jaad.2021.06.107.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Blom, A., L. Mortier, I. Kachaner, et al. "RWD87 Retrospective Observational Study of Patients with Metastatic Merkel Cell Carcinoma (mMCC) Using the Caraderm Database Linked to the French National Health Data System (SNDS)." Value in Health 26, no. 12 (2023): S520. http://dx.doi.org/10.1016/j.jval.2023.09.2804.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Tanguy-Melac, Audrey, Dorian Verboux, Laurence Pestel, Anne Fagot-Campagna, Philippe Tuppin, and Christelle Gastaldi-Ménager. "Evolution of health care utilization and expenditure during the year before death in 2015 among people with cancer: French snds-based cohort study." European Journal of Health Economics 22, no. 7 (2021): 1039–52. http://dx.doi.org/10.1007/s10198-021-01304-1.

Full text
Abstract:
Abstract Background Cancer patients have one of the highest health care expenditures (HCE) at the end of life. However, the growth of HCE at the end of life remains poorly documented in the literature. Objective To describe monthly reimbursed expenditure during the last year of life among cancer patients, by performing detailed analysis according to type of expenditure and the person’s age. Method Data were derived from the Système national des données en santé (SNDS) [national health data system], which comprises information on ambulatory and hospital care. Analyses focused on general scheme
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "French National Health Data System (SNDS)"

1

Laanani, Moussa. "Étude des relations entre l’état de santé, sa prise en charge et le décès par suicide à partir du Système national des données de santé Contacts with Health Services During the Year Prior to Suicide Death andPrevalent Conditions A Nationwide Study Collider and Reporting Biases Involved in the Analyses of Cause of Death Associations in Death Certificates: an Illustration with Cancer and Suicide." Thesis, université Paris-Saclay, 2020. http://www.theses.fr/2020UPASR016.

Full text
Abstract:
Le suicide représente un problème de santé publique majeur en France avec près de 10 000 décès prématurés chaque année. L'étude des déterminants du suicide est complexe. Il s'agit d’un phénomène plurifactoriel, pouvant être influencé par des éléments personnels et/ou environnementaux, bio-médicaux et/ou socio-économiques. La présence de pathologies (psychiatriques ou somatiques) chez l'individu joue un rôle important. Les pathologies psychiatriques peuvent se compliquer de processus suicidaires (idées suicidaires, pouvant être suivies de comportements suicidaires, puis d'un décès par suicide).
APA, Harvard, Vancouver, ISO, and other styles
2

Swital, Morgane. "Utilisation des Médicaments Innovants de la Sclérose en Plaques Pendant la Grossesse et Risques Associés." Electronic Thesis or Diss., université Paris-Saclay, 2024. http://www.theses.fr/2024UPASR037.

Full text
Abstract:
La sclérose en plaques (SEP) est une maladie chronique du système nerveux central qui touche particulièrement les femmes jeunes en âge de procréer. L'arrivée sur le marché de nombreux médicaments innovants et efficaces au cours de la dernière décennie a engendré un besoin accru de données sur leur sécurité, notamment en cas de grossesse. Cette thèse avait pour objectif général d'évaluer l'utilisation et les risques associés à ces traitements pendant la grossesse au cours de la dernière décennie en France à partir du registre mères-enfants EPI-MERES. Dans une première étude, nous avons inclus u
APA, Harvard, Vancouver, ISO, and other styles
3

Heurteau, Foulon Stéphanie. "Prévalence, qualité de vie et coût de la Leucémie Myéloïde Chronique en France Using healthcare claims data to analyze the prevalence of BCR-ABL-positive chronic myeloid leukemia in France: A nationwide population-based study Health state utility and quality of life measures in patients with chronic myeloid leukemia in France." Thesis, Université Paris-Saclay (ComUE), 2019. http://www.theses.fr/2019SACLS574.

Full text
Abstract:
La leucémie myéloïde chronique (LMC) est une hémopathie maligne rare dont le pronostic a été transformé à partir des années 2000 par les inhibiteurs de tyrosine kinase (ITK). L’augmentation spectaculaire de l’espérance de vie des patients a conduit à une augmentation de la prévalence de la LMC. D’une maladie mortelle à moyen terme, la LMC est devenue une maladie chronique nécessitant la prise quotidienne d’ITK pendant plusieurs années. Les ITK sont des traitements onéreux qui, pris au long cours par un nombre croissant de patients, augmentent le fardeau économique de la maladie. Ces traitement
APA, Harvard, Vancouver, ISO, and other styles
4

Roux, Jonathan. "Parcours de soins des patients atteints de sclérose en plaques à partir des données médico-administratives en France." Thesis, Rennes 1, 2018. http://www.theses.fr/2018REN1B042/document.

Full text
Abstract:
La sclérose en plaques (SEP) est une maladie neurologique chronique du jeune adulte affectant environ 100 000 personnes en France. Au cours des deux dernières décennies, les stratégies thérapeutiques ont fortement évolué avec l’apparition de nouvelles molécules dont les premières formes orales. Le parcours de soins dans la SEP implique plusieurs professionnels de santé médicaux (généralistes, neurologues) et paramédicaux (kinésithérapeutes, infirmiers). Actuellement, aucune recommandation sur ces parcours n’a été définie, et peu de données existent sur le recours aux soins des individus ayant
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "French National Health Data System (SNDS)"

1

"Further Information on the système national des données de santé (National Healthcare Data System – SNDS) in France." In Health Data Processing. Elsevier, 2018. http://dx.doi.org/10.1016/b978-1-78548-287-8.50028-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Quindroit, Paul, Antoine Teston, Nicolas Millevile, Emmanuel Chazard, Chloé Saint-Dizier, and Antoine Lamer. "Home Care Nursing on Long-Term Illness Management in the French Healthcare System." In Studies in Health Technology and Informatics. IOS Press, 2024. http://dx.doi.org/10.3233/shti240286.

Full text
Abstract:
This study explores the role of home care nurses in managing long-term illnesses (L-TI) within the French healthcare system, utilizing data from the SNDS. Focused on data from 2022, it categorizes nursing actions into medical procedures, care procedures, and nursing processes, revealing significant involvement in patient care. The findings highlight the crucial, evolving role of home care nurses in addressing the complex needs of millions suffering from chronic conditions like diabetes and cardiovascular diseases in France.
APA, Harvard, Vancouver, ISO, and other styles
3

Cuggia, Marc, Leslie Guillon-Grammatico, Pierre-Antoine Gourraud, et al. "The Ouest Data Hub: An Interregional Health Data Sharing Ecosystem for Research." In Studies in Health Technology and Informatics. IOS Press, 2024. http://dx.doi.org/10.3233/shti240746.

Full text
Abstract:
The Ouest Data Hub (ODH) a project lead by GCS HUGO which is a cooperation group of University Hospitals in the French Grand Ouest region represents a groundbreaking initiative in this territory, advancing health data sharing and reuse to support research driven by real-world health data. Central to its structure are the Clinical Data Warehouses (CDWs) and Clinical Data Centers (CDCs), essential for analytics and as the linchpin of the ODH’s status as an interregional Learning Health System. Aimed at fostering innovation and research, the ODH’s collaborative and multi-institutional model effectively utilizes both local and shared resources. Yet, the path is not without challenges, especially in data quality and interoperability, where ongoing harmonization and standard adherence are critical. In 2023, this facilitated access to extensive health data from over 9.3 million patient records, demonstrating the ODH’s capacity for both monocentric and multicentric research across various clinical fields, in close collaboration with physicians. The integration of healthcare professionals is crucial, ensuring data’s clinical relevance and guiding accurate interpretations. Future expansions of the ODH to new hospitals and data types promise to enhance its model further, already inspiring similar frameworks across France. This scalable model for health data ecosystems showcases the ODH’s potential as a foundation for national and supranational data sharing efforts
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "French National Health Data System (SNDS)"

1

Miceli Richard, C., R. Curmin, B. Flachaire, S. Pinto, F. Tubach, and T. Pham. "POS0809 SWITCH OR SWAP? SECOND TARGETED THERAPY CHOICE IN PATIENTS WITH SPONDYLOARTHRITIS: A COHORT STUDY WITHIN THE FRENCH NATIONAL HEALTH DATA SYSTEM (SNDS)." In EULAR 2024 European Congress of Rheumatology, 12-15 June. Vienna, Austria. BMJ Publishing Group Ltd and European League Against Rheumatism, 2024. http://dx.doi.org/10.1136/annrheumdis-2024-eular.4966.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Nasser, Mouhamad, Sophie Larrieu, Loic Boussel, et al. "Prevalence and mortality of systemic sclerosis-associated interstitial lung disease (SSc-ILD) using the French national health insurance system (SNDS) database in France." In ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.805.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Nasser, Mouhamad, Sophie Larrieu, Loïc Boussel, et al. "Epidemiology and mortality of non-idiopathic pulmonary fibrosis (IPF) progressive fibrosing interstitial lung disease (PF-ILD) using the French national health insurance system (SNDS) database in France: the PROGRESS study." In ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.444.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

De Maleprade, B., E. Lacroix, J. Grosjean, O. Vittecoq, and T. Lequerré. "AB0879 POST-PARTUM SPONDYLOARTHRITIS AND RESPONSE TO ANTI-TNFA: RESULTS FROM A SINGLE-CENTER STUDY AND THE FRENCH NATIONAL HEALTH DATA SYSTEM DATABASE." In EULAR 2024 European Congress of Rheumatology, 12-15 June. Vienna, Austria. BMJ Publishing Group Ltd and European League Against Rheumatism, 2024. http://dx.doi.org/10.1136/annrheumdis-2024-eular.2064.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'French National Health Data System (SNDS)' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography